Bellevue Asset Management (Switzerland)’s Alexion Pharmaceuticals ALXN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio ALXN Stock Details ALXN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$9.42M	Hold
2015 Q3	$7.73M	Sell
2015 Q2	$9.35M	Sell
2015 Q1	$12.6M	Buy